Total Payments
$170,624
2024 Payments
$16,063
Companies
25
Transactions
203
Medicare Patients
2,351
Medicare Billing
$457,641
Payment Breakdown by Category
Other$121,393 (71.1%)
Consulting$22,895 (13.4%)
Travel$18,002 (10.6%)
Food & Beverage$8,326 (4.9%)
Education$8.54 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $119,972 | 45 | 70.3% |
| Consulting Fee | $22,895 | 10 | 13.4% |
| Travel and Lodging | $18,002 | 41 | 10.6% |
| Food and Beverage | $8,326 | 104 | 4.9% |
| Honoraria | $1,300 | 1 | 0.8% |
| Grant | $121.00 | 1 | 0.1% |
| Education | $8.54 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $88,455 | 81 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $30,146 | 31 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $13,809 | 13 | $0 (2024) |
| PROGENICS PHARMACEUTICALS, INC. | $10,962 | 17 | $0 (2024) |
| PFIZER INC. | $9,184 | 18 | $0 (2024) |
| Astellas Pharma US Inc | $6,044 | 5 | $0 (2023) |
| Myovant Sciences Inc. | $3,950 | 1 | $0 (2021) |
| Advanced Accelerator Applications | $2,000 | 1 | $0 (2020) |
| AngioDynamics, Inc. | $2,000 | 1 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $1,425 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16,063 | 26 | Janssen Biotech, Inc. ($9,547) |
| 2023 | $45,521 | 48 | Janssen Biotech, Inc. ($35,204) |
| 2022 | $15,986 | 25 | Progenics Pharmaceuticals, Inc. ($7,515) |
| 2021 | $7,942 | 10 | Myovant Sciences Inc. ($3,950) |
| 2020 | $28,567 | 25 | Bayer HealthCare Pharmaceuticals Inc. ($11,422) |
| 2019 | $29,332 | 39 | Janssen Biotech, Inc. ($25,386) |
| 2018 | $24,341 | 17 | Janssen Scientific Affairs, LLC ($18,123) |
| 2017 | $2,872 | 13 | Janssen Scientific Affairs, LLC ($2,283) |
All Payment Transactions
203 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/08/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $122.83 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $130.32 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $113.95 | General |
| Category: Oncology | ||||||
| 11/09/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $103.15 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $675.00 | General |
| Category: Oncology | ||||||
| 08/22/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Consulting Fee | Cash or cash equivalent | $2,700.00 | General |
| Category: Oncology | ||||||
| 08/11/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $40.58 | General |
| Category: Diagnostic Imaging | ||||||
| 08/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $124.72 | General |
| Category: Oncology | ||||||
| 08/09/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $86.48 | General |
| Category: Oncology | ||||||
| 08/08/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Travel and Lodging | In-kind items and services | $559.07 | General |
| Category: Oncology | ||||||
| 06/28/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $147.64 | General |
| Category: Oncology | ||||||
| 06/27/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.98 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/03/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $86.12 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 04/27/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $131.50 | General |
| Category: ONCOLOGY | ||||||
| 03/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $675.00 | General |
| Category: Oncology | ||||||
| 02/28/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,070.00 | General |
| Category: Oncology | ||||||
| 02/21/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Travel and Lodging | In-kind items and services | $290.75 | General |
| Category: Oncology | ||||||
| 02/20/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Travel and Lodging | In-kind items and services | $290.75 | General |
| Category: Oncology | ||||||
| 02/14/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Travel and Lodging | In-kind items and services | $863.15 | General |
| Category: Oncology | ||||||
| 02/13/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: Oncology | ||||||
| 02/12/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $129.03 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 01/31/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: OS | ||||||
| 01/26/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $6.76 | General |
| Category: Oncology | ||||||
| 01/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,012.50 | General |
| Category: Oncology | ||||||
| 01/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Travel and Lodging | In-kind items and services | $465.21 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 601 | 670 | $925,433 | $101,798 |
| 2022 | 13 | 579 | 640 | $927,378 | $103,567 |
| 2021 | 16 | 619 | 785 | $1.4M | $128,596 |
| 2020 | 15 | 552 | 726 | $1.5M | $123,680 |
Total Patients
2,351
Total Services
2,821
Medicare Billing
$457,641
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2023 | 26 | 26 | $300,831 | $26,614 | 8.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 88 | 117 | $112,320 | $17,404 | 15.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 146 | $125,268 | $14,429 | 11.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 79 | 79 | $107,440 | $14,301 | 13.3% |
| 38571 | Removal of lymph nodes of both sides of pelvis using an endoscope | Facility | 2023 | 27 | 27 | $119,610 | $8,488 | 7.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 106 | $53,848 | $7,374 | 13.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 24 | 25 | $28,125 | $5,411 | 19.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $42,315 | $4,515 | 10.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 35 | 35 | $30,240 | $2,686 | 8.9% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2023 | 40 | 44 | $2,904 | $402.70 | 13.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 13 | 14 | $2,100 | $132.34 | 6.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 11 | 12 | $432.00 | $40.92 | 9.5% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2022 | 33 | 33 | $376,741 | $38,972 | 10.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 79 | 96 | $92,160 | $14,797 | 16.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 72 | 72 | $97,920 | $12,680 | 12.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 91 | 112 | $96,096 | $10,964 | 11.4% |
| 38571 | Removal of lymph nodes of both sides of pelvis using an endoscope | Facility | 2022 | 25 | 25 | $110,750 | $6,810 | 6.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 43 | 43 | $46,655 | $5,366 | 11.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 79 | $40,132 | $5,102 | 12.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 20 | 22 | $24,750 | $4,604 | 18.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 36 | 36 | $31,104 | $2,871 | 9.2% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2022 | 38 | 45 | $2,970 | $575.49 | 19.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 18 | 18 | $1,530 | $387.46 | 25.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 35 | 39 | $5,850 | $367.28 | 6.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 19 | 20 | $720.00 | $69.02 | 9.6% |
About Dr. Robert Reiter, MD
Dr. Robert Reiter, MD is a Surgical Oncology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346269297.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Reiter, MD has received a total of $170,624 in payments from pharmaceutical and medical device companies, with $16,063 received in 2024. These payments were reported across 203 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($119,972).
As a Medicare-enrolled provider, Reiter has provided services to 2,351 Medicare beneficiaries, totaling 2,821 services with total Medicare billing of $457,641. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgical Oncology
- Other Specialties Urology
- Location Los Angeles, CA
- Active Since 07/19/2006
- Last Updated 01/09/2020
- Taxonomy Code 2086X0206X
- Entity Type Individual
- NPI Number 1346269297
Products in Payments
- ERLEADA (Drug) $60,647
- Erleada (Drug) $52,526
- XTANDI (Drug) $10,129
- Nubeqa (Drug) $8,754
- PYLARIFY (Drug) $8,487
- Xofigo (Drug) $5,055
- Xtandi (Drug) $4,850
- ORGOVYX (Drug) $3,950
- LUTATHERA (Drug) $2,000
- NANOKNIFE (Device) $2,000
- ELIGARD (Drug) $1,425
- NO PRODUCT DISCUSSED (Drug) $831.31
- Da Vinci Surgical System (Device) $327.48
- LYNPARZA (Drug) $281.21
- Axumin (Drug) $203.04
- PROVENGE (Drug) $172.00
- POSLUMA (Drug) $166.67
- ZYTIGA (Drug) $152.61
- FIRMAGON (Drug) $117.60
- TALZENNA (Drug) $88.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgical Oncology Doctors in Los Angeles
Karim Chamie, M.d, M.D
Surgical Oncology — Payments: $222,147
Surgical Oncology $222,147
Lawrence Menendez, M.d, M.D
Surgical Oncology — Payments: $50,396
Surgical Oncology $50,396
Cristina Ferrone, M.d, M.D
Surgical Oncology — Payments: $35,968
Surgical Oncology $35,968
Dr. Arnold Chin, Md, Phd, MD, PHD
Surgical Oncology — Payments: $35,897
Surgical Oncology $35,897
Dr. John Kang, M.d, M.D
Surgical Oncology — Payments: $33,340
Surgical Oncology $33,340
James Economou, Md, MD
Surgical Oncology — Payments: $26,550
Surgical Oncology $26,550